Novo-Passit tab. p / o captivity. 357.5mg # 60

Dosage form

Film-coated tablets

Structure

Novo-Passit dry extract (obtained from rhizomes with roots of valerian officinalis, herb of lemon balm, herb St. John's wort, leaves and flowers of hawthorn or prickly hawthorn, herb of passionflower (passionflower), seed hops, elderberry flowers, black guaifenes) 157.5 mg mg

Excipients: colloidal silicon dioxide, microcrystalline cellulose, glycerol, magnesium stearate, lactose monohydrate.

Shell composition: opadry AMB 80W31115" green (polyvinyl alcohol, titanium dioxide, talc, soy lecithin, xanthan gum, quinoline yellow dye, iron oxide yellow, indigo carmine dye).

pharmachologic effect

Combined phytopreparation with a sedative effect, pharmacological activity is due to the components of the extract based on medicinal raw materials with a predominantly sedative effect and guaifenesin, which has an anxiolytic effect.

The sedative effect of the drug is complemented by the anxiolytic effect of guaifenesin.

Side effects

From the digestive system: rarely - nausea, vomiting, cramps, heartburn, diarrhea, constipation are possible.

From the side of the central nervous system: rarely - decreased concentration, dizziness, drowsiness.

Others: rarely - allergic reactions, exanthema, fatigue, slight muscle weakness.

Symptoms quickly subside after drug withdrawal.

The patient should be warned that if these or other adverse reactions occur, it is necessary to consult a doctor.

Selling features

Available without a prescription

Special conditions

Alcohol should not be consumed during the treatment with Novo-Passit®.

The drug should be used with caution in acute gastrointestinal diseases.

The patient should be warned that if within 7 days of therapy the symptoms of the disease do not disappear or if they intensify, it is recommended to consult a doctor.

While taking Novo-Passit®, you should avoid exposure to ultraviolet radiation (prolonged exposure to direct sunlight, visiting a solarium), especially for patients with fair skin.

The drug in the form of a solution is not recommended for use in patients with impaired absorption of glucose and galactose and congenital fructose intolerance.

Patients with diabetes mellitus should keep in mind that 100 g of oral solution contains 12.5-14.2 g of glucose and 13.6-15.3 g of fructose.

When taken in recommended doses, each dose contains no more than 1.42 g glucose and 1.53 g fructose.

The oral solution contains 12.19% ethanol

each single dose contains up to 0.481 g of ethanol.

Influence on the ability to drive vehicles and use mechanisms

During the period of treatment, it is necessary to refrain from engaging in potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions.

You should not drive vehicles and mechanisms.

Indications

- neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, distraction

- "manager's syndrome" (a state of constant mental stress)

- insomnia (mild forms)

- headaches caused by nervous tension

- migraine

- functional gastrointestinal diseases (dyspeptic syndrome, irritable bowel syndrome)

- as a symptomatic remedy for neurocirculatory dystonia and climacteric syndrome

- itchy dermatoses (atopic and seborrheic eczema, urticaria) caused by psychological stress.

Contraindications

- myasthenia gravis

- children up to age 12

- hypersensitivity to drug components.

The drug should be used with caution in patients with acute gastrointestinal diseases, liver diseases, chronic alcoholism,

Name ENG

NOVO-PASSIT

Clinical and pharmacological group

Sedative

ATX code

Other hypnotics and sedatives

Dosage

200mg + 157.5mg

Structure

Novo-Passit dry extract (obtained from rhizomes with roots of Valerian officinalis, herb of lemon balm, herb St. John's wort, leaves and flowers of hawthorn or prickly hawthorn, Passiflora herb (passionflower), seed hops, elderberry flowers, black guaifenes) 157.5 mg mg.

Excipients: colloidal silicon dioxide, microcrystalline cellulose, glycerol, magnesium stearate, lactose monohydrate.

Shell composition: opadry "AMB 80W31115" green (polyvinyl alcohol, titanium dioxide, talc, soy lecithin, xanthan gum, quinoline yellow dye, iron oxide yellow, indigo carmine dye).

Indications

Neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, distraction

"manager" syndrome (a state of constant mental stress)

insomnia (mild forms)

headaches caused by nervous tension, migraines, functional gastrointestinal diseases (dyspeptic syndrome, irritable bowel syndrome), climacteric syndrome, neurocirculatory dystonia, itchy dermatoses (atopic and seborrheic eczema, urticaria) caused by psychological stress.

INN / Active ingredient

Novo-passita dry extract + guaifenesin

Contraindications

Hypersensitivity to the components of the drug, myasthenia gravis, children under 12 years of age.

The drug should be used with caution in patients with acute gastrointestinal diseases, liver diseases, chronic alcoholism, diseases and brain injuries, and epilepsy.

Storage conditions and periods

In a dark place at a temperature of 10-25 degrees.

Expiration date: 3 years

Specifications

Category

Sedatives

,

Antipsychotics

,

Neurological disorders

Scope of the drug

Neurology, psychiatry

Release form

Tablet

Manufacturer country

Czech

Package quantity, pcs

60

Scope of application

Cardiology

Minimum age from

12 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Novo-Passit

The amount of the dosage form in the primary package

60 pcs.

Primary packaging type

Polyethylene can

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal sedative

Anatomical and therapeutic characteristics

N05CM Other hypnotics and sedatives

Dosage form

Film-coated tablets

The target audience

Children

Expiration date in days

1095

Package weight, g

one hundred

Mode of application

:

Inside, adults and children over 12 years old are prescribed 1 tablet or 5 ml of solution for oral administration 3 before meals.

If necessary, according to the doctor's prescription, it is possible to increase the dose to 2 tablets or 10 ml of solution 3 In case of severe fatigue or depression, it is necessary to reduce the morning and afternoon dose to 1/2 tablet or to 2.5 ml of solution per dose, in the evening take 1 tablet or 5 ml solution.

The interval between doses should be 4-6 hours. < br> In case of nausea, the drug should be taken with meals.

< br> The drug in the form of a solution is taken undiluted or diluted in a little water.

When using the drug in a vial, dosing is carried out using a measuring cap.

Dosage (volume) of the substance in the preparation

:

dry extract of medicinal plants Novo-Passit 157.5 mg, guaifenesin 200 mg

Information on technical characteristics, delivery set, country of manufacture "